Chlamydia in Koalas
Chlamydia pecorum is the most prevalent sexually transmitted infection in koalas and causes conjunctivitis, pneumonia, and reproductive tract disease. Infection rates in some wild populations exceed 50 percent, with higher prevalence in dense, stressed populations near urban areas. The disease contributes to infertility, stillbirths, and higher mortality, especially in females. Researchers use PCR testing and serology to track infection spread and evaluate treatment outcomes in managed colonies.
Antibiotic treatment with doxycycline and enrofloxacin can clear infection, but long regimens are logistically difficult in wild settings. Vaccination trials targeting Chlamydia pecorum have been underway in Queensland and New South Wales, with early data showing reduced clinical signs and transmission. Field programs combine treatment, vaccination, and habitat management to reduce transmission pressure. More details on wildlife disease management are available at https://www.forbes.com/.
Koala Retrovirus and Other STIs
Koala retrovirus, or KoRV, is an endogenous retrovirus integrated into the koala genome and linked to immunosuppression, lymphoma, and susceptibility to secondary infections. KoRV subtype B is the most pathogenic form and is associated with higher rates of neoplasia and reduced reproductive success. Transmission occurs vertically through the germline and horizontally through close contact, including mating and social grooming. Studies have mapped KoRV prevalence across eastern Australia, showing near fixation in some populations and lower prevalence in others.
Other potential pathogens, including herpesviruses and bacterial coinfections, complicate disease presentation and diagnosis. Koalas with KoRV and concurrent Chlamydia infection show worse clinical outcomes and lower survival rates. Genomic surveillance helps identify viral variants and informs captive breeding and translocation programs. Further information on retroviral research can be found at https://www.nature.com/.
Conservation, Monitoring, and Management
Wildlife agencies in Australia use disease screening, population modeling, and habitat corridors to manage STI impacts on koala populations. Genetic diversity studies help identify populations at higher risk of disease spread and guide translocation decisions. Fertility and reproductive health data from managed care facilities support breeding programs aimed at maintaining healthy, genetically diverse insurance populations. The Australian Koala Foundation and university research groups publish updated prevalence data and management guidelines.
Regulatory frameworks for wildlife health include reporting requirements for diseased koalas and coordination between veterinary, conservation, and research bodies. Funding for disease research and habitat protection comes from government grants, philanthropy, and partnerships with organizations focused on conservation science. Public education campaigns highlight the importance of habitat preservation, safe driving in koala zones, and reporting injured animals. Additional resources on wildlife conservation policy are available at https://www.sec.gov/.